About Sanofi 
Sanofi
Pharmaceuticals & Biotechnology
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
Company Coordinates 
Company Details
54 rue la Boetie , PARIS None : 75008
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 6 Foreign Institutions (0.03%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Serge Weinberg
Independent Chairman of the Board
Mr. Paul Hudson
Chief Executive Officer, Member of the Executive Committee, Director
Mr. Laurent Attal
Director
Mr. Christophe Babule
Director
Mr. Bernard Charles
Independent Director
Ms. Claudie Haignere
Independent Director
Mr. Patrick Kron
Independent Director
Revenue and Profits:
Net Sales:
8,810 Million
(Quarterly Results - Mar 2015)
Net Profit:
1,055 Million
Pharmaceuticals & Biotechnology
EUR 105,746 Million ()
14.00
NA
4.57%
0.08
10.62%
1.51






